HIP1R and pancreatic adenocarcinoma: The promoter region of HIP1R was heavily methylated in PAAD cell lines, and the treatment of a DNA methylation inhibitor 5‐AZA increased HIP1R expression and impaired the malignant phenotype of PAAD cells.